Kiromic Biopharma Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors. | |||
Founding Date | Founding Date 2001 | Founding Date 2012 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Lund, SE HQ | Locations Houston, US HQ | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more |
Employees | Employees 1555% decrease | Employees 4426% increase | Employees 3,9671% decrease |
Valuation ($) | Valuation ($) 59 m | Valuation ($) 1.8 m | Valuation ($) N/A |
Financial | |||
Net income | Net income (kr51.4m) (FY, 2025) | Net income ($26.9m) (FY, 2024) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 135k | Total funding raised $ 85.3m |
Kiromic BioPharma (formerly known as Kiromic) is a target discovery and gene editing company focusing on developing immuno-oncology therapeutics for the treatment of blood cancers and solid tumors.
View company
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
View company